The Moore Innovations Foundation

CAR-T Therapy at $20,000 — For Every Child in America

Our Mission

We are planning on building a nonprofit CAR-T manufacturing center in Tifton, Georgia to deliver life-saving immunotherapy at 1/20th the cost of commercial therapies — $20,000 per dose, $0 to families.

Starting with relapsed B-cell leukemia (B-ALL), we will treat 100 children in Year 1, then scale to 500+ annually, and expand to all 70 pediatric cancers.

Insurance pays. Families never see a bill. Surplus funds the next cure.

Why $20K Works

Commercial CAR-T	Moore Innovations
$475,000–$800,000	$20,000
6–12 month wait	14-day turnaround
Boston / NYC only	Tifton, GA + nationwide shipping
Profit-driven	501(c)(3) — surplus reinvested

How It Works

A child relapses — anywhere in the U.S.
Local hospital draws blood — ships to Tifton overnight
We engineer CAR-T cells — 14-day GMP process
Ship frozen dose back — infused locally
Insurance pays $100K → $80K surplus funds the next 4 patients

Phase 1: CD19 CAR-T (2026)

Target: Relapsed B-ALL
Cost: $20,000
Patients: 100 in Year 1
Outcome Goal: 90% complete remission

Phase 2: All Pediatric Cancers (2027+)

Using surplus revenue:

CD22 — AML, ALL
GD2 — Neuroblastoma
BCMA — Multiple Myeloma
Multi-CAR — Solid Tumors

Built in South Georgia — For the Nation

20,000 sq ft GMP facility — Tifton, GA
20 local jobs — $50K–$180K
100% GA tax abatements
Powered by UGA, St. Jude, COG network

No Family Pays. Ever.

501(c)(3) nonprofit
Insurance covers 100%
Medicaid, BCBS, United, Aetna, Tricare — all in-network
National referral network — 220+ pediatric hospitals

BUT HOW WILL IT BE FUNDED?

Moore Innovations Foundation will be fully funded by the anticipated $75M sale of the VOLT prototype. The founder will allocate $15M in liquid capital to build a 20,000 sq ft GMP facility in Tifton, GA, targeting first patient in 12 months. With $20K production cost and $100K insurance reimbursement, each dose will generate $80K surplus — creating a self-funding cure engine that will scale to 500+ pediatric patients annually with zero family billing. No further investment required. $75M VOLT Sale Will → $15M Seed for Moore Innovations The VOLT prototype — a breakthrough EV Technician Portable Tool — will be sold for $75M upon commercialization. Founder will personally commit $15M to launch Moore Innovations Foundation in Tifton, GA:

$4M GMP facility
$3.5M equipment
$5M 3-year team
$2.5M land + clinical

Remaining ~$41M post-tax reserve — no dilution, no debt.

Self-sustaining from Day 1:

Insurance will pay $100K/dose → $80K surplus
100 patients Year 1 = $8M revenue → $5M surplus
Will fund 250+ patients Year 2 — no donations needed

Join Us

Doctors: Refer patients; Donors: Fund a dose → $20,000 saves a life; Talent: GMP techs, scientists; Partners: Hospitals, insurers → [email protected]

Every child funded by the ones before.